Logo
x

Search

Subscribe Now

abbott

The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

  • June 11, 2024
Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

  • June 7, 2024
Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)

Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)

  • April 30, 2024
Abbott’s Triclip Transcatheter Edge-To-Edge Repair System Gains the US FDA’s Approval for the Treatment of Tricuspid Regurgitation

Abbott’s Triclip Transcatheter Edge-To-Edge Repair System Gains the US FDA’s Approval for the Treatment of Tricuspid Regurgitation

  • April 3, 2024
Abbott’s Whole Blood Rapid Test Gains the US FDA’s Clearance to Evaluate Concussion

Abbott’s Whole Blood Rapid Test Gains the US FDA’s Clearance to Evaluate Concussion

  • April 2, 2024
Abbott Reports Data from the Real-World Studies of Freestyle Libre Systems and GLP-1 Therapy in Patients with Type 2 Diabetes

Abbott Reports Data from the Real-World Studies of Freestyle Libre Systems and GLP-1 Therapy in Patients with Type 2 Diabetes

  • March 7, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.